plerixafor has been researched along with Hypertension, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, S; Auer, N; Chakraborty, A; Condon, D; de Jesus Perez, VA; Liu, Y; Nathan, A; Nicolls, MR; Shamshou, EA; Sweatt, AJ; Tian, W; Wu, JC; Yu, J; Yuan, K; Zamanian, RT; Zhang, S; Zhang, Y | 1 |
| Bonnet, D; Bordenave, J; Cumont, A; Frossard, N; Galzi, JL; Guignabert, C; Hibert, M; Huertas, A; Humbert, M; Marsol, C; Phan, C; Savale, L; Thuillet, R; Tu, L | 1 |
| Alhussaini, AA; Bogaard, HJ; Cool, CD; Drake, JI; Farkas, D; Farkas, L; Kraskauskas, D; Kraskauskiene, V; Voelkel, NF | 1 |
| Drummond, S; Hehre, D; Huang, J; Ramachandran, S; Suguihara, C; Torres, E; Young, KC | 1 |
| Hare, JM; Hatzistergos, KE; Hehre, D; Suguihara, C; Torres, E; Young, KC | 1 |
| Cohen-Kaminsky, S; Gambaryan, N; Humbert, M; Lombet, A; Mazmanian, M; Montani, D; Perros, F; Renaud, JF; Simonneau, G | 1 |
| Hales, CA; Yu, L | 1 |
7 other study(ies) available for plerixafor and Hypertension, Pulmonary
| Article | Year |
|---|---|
Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension.
Topics: Animals; Antigens; Benzylamines; Cell Division; Cell Lineage; Chemokine CXCL12; Chronic Disease; Cyclams; DNA Nucleotidylexotransferase; Gene Expression Regulation; Gene Knockdown Techniques; Heterocyclic Compounds; Hypertension, Pulmonary; Hypoxia; Mice; Mice, Transgenic; Models, Biological; Myocytes, Smooth Muscle; Pericytes; Proteoglycans; Receptors, CXCR4; Recombinant Proteins; RNA, Messenger; Signal Transduction; Vasoconstriction | 2020 |
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Topics: Animals; Benzylamines; Cell Movement; Cell Proliferation; Cells, Cultured; Chalcones; Chemokine CXCL2; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Macrophages; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pericytes; Pulmonary Artery; Pyrimidinones; Rats, Wistar; Receptors, CXCR4; Signal Transduction; Vascular Remodeling; Vascular Resistance | 2020 |
CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats.
Topics: Actins; Analysis of Variance; Animals; Arterial Occlusive Diseases; Benzylamines; Cyclams; Fluorescent Antibody Technique; Heterocyclic Compounds; Hypertension, Pulmonary; Immunohistochemistry; In Situ Hybridization; Indoles; Microscopy, Confocal; Proto-Oncogene Proteins c-kit; Pyrroles; Rats; Receptors, CXCR4; von Willebrand Factor | 2014 |
CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.
Topics: Animals; Animals, Newborn; Benzylamines; Bronchopulmonary Dysplasia; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperoxia; Hypertension, Pulmonary; Inflammation; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Receptors, CXCR4 | 2015 |
Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension.
Topics: Animals; Animals, Newborn; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Cyclams; Heart Ventricles; Heterocyclic Compounds; Humans; Hypertension, Pulmonary; Hypoxia; Infant, Newborn; Infant, Premature; Mice; Pulmonary Circulation; Receptors, CXCR4; Systole; Ventricular Remodeling | 2009 |
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.
Topics: Animals; Antigens, Ly; Benzylamines; Chemokine CXCL12; Cyclams; Hematopoietic Stem Cells; Heterocyclic Compounds; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-kit; Receptors, CXCR; Receptors, CXCR4 | 2011 |
Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats.
Topics: Animals; Benzylamines; Blood Pressure; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Cyclams; Disease Models, Animal; Electroporation; Green Fluorescent Proteins; Heterocyclic Compounds; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, CXCR4; RNA Interference; Stem Cells; Transfection | 2011 |